What is Solvemed?
Solvemed is an innovative player in the Information Technology and Services sector, with a specialized focus on neurodegenerative diseases, particularly dementias. The company leverages proprietary machine learning technology to create first-in-class digital biomarkers. These biomarkers are designed to support the development of neurological drugs, while also enabling the establishment of affordable clinical examination and remote monitoring tools. Headquartered in London, England, Solvemed is positioned at the intersection of healthcare technology and advanced data analytics, aiming to revolutionize the approach to neurological disease management and research.
How much funding has Solvemed raised?
Solvemed has raised a total of $3.5M across 1 funding round:
Other Financing Round
$3.5M
Other Financing Round (2022): $3.5M with participation from APEX Ventures, Tensor Ventures, Atmos Ventures, and Techni Ventures
Key Investors in Solvemed
APEX Ventures
APEX Ventures is a venture capital firm specializing in deep-tech and medical innovations, dedicated to building world-leading companies. They provide crucial guidance and resources to early-stage startups, particularly those with disruptive technology in the medical field.
Tensor Ventures
Tensor Ventures is a venture capital firm focused on combinatorial technologies, including AI and Computational Biotech. They invest in niche, disruptive startups, often participating in Seed and Series A rounds with a global reach.
Atmos Ventures
ATMOS Ventures is a Deep Tech Venture Capital firm based in Central and Eastern Europe, investing in innovative teams tackling complex scientific challenges. They focus on cutting-edge technologies like AI and robotics.
What's next for Solvemed?
The recent major enterprise-level funding signifies a critical growth phase for Solvemed. This capital injection is expected to accelerate the company's research and development efforts, expand its technological capabilities, and potentially broaden its market reach. With a clear focus on digital biomarkers for neurological conditions, Solvemed is poised to play a pivotal role in advancing drug discovery and improving patient care through innovative digital solutions. The strategic backing from prominent investors suggests a strong market validation and a promising trajectory for future scaling and impact in the healthcare technology landscape.
See full Solvemed company page
